Vanda Pharmaceuticals Inc. - COMMON STOCK (VNDA)
CUSIP: 921659108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 59,128,667
- Total 13F shares
- 43,532,710
- Share change
- -4,516,218
- Total reported value
- $245,988,772
- Put/Call ratio
- 167%
- Price per share
- $5.65
- Number of holders
- 147
- Value change
- -$20,221,284
- Number of buys
- 81
- Number of sells
- 76
Quarterly Holders Quick Answers
What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 921659108:
Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
14%
|
8,139,881
|
$33,454,910 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
7.2%
|
4,275,625
|
$17,573,000 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.7%
|
3,395,583
|
$13,955,845 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
4%
|
2,370,335
|
$9,740,000 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
3%
|
1,802,842
|
$7,409,680 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
3%
|
1,751,654
|
$7,199,298 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.9%
|
1,721,635
|
$7,075,920 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.6%
|
1,508,648
|
$6,200,544 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
2.4%
|
1,419,560
|
$5,834,392 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
1,245,382
|
$5,119,130 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2%
|
1,208,261
|
$4,965,952 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
1,203,295
|
$4,945,542 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
1.9%
|
1,098,480
|
$4,514,753 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.7%
|
1,013,251
|
$4,164,462 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.2%
|
730,820
|
$3,003,670 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
725,239
|
$2,980,732 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.2%
|
715,670
|
$2,941,404 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.2%
|
703,900
|
$2,893,029 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.2%
|
692,878
|
$2,847,729 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.1%
|
668,180
|
$2,746,220 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.9%
|
532,280
|
$2,187,671 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.89%
|
526,383
|
$2,163,434 | — | 31 Mar 2024 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.88%
|
518,851
|
$2,132,478 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.85%
|
505,385
|
$2,077,132 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.84%
|
494,740
|
$2,033,382 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.83%
|
489,324
|
$2,011,000 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.74%
|
435,767
|
$1,791,002 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.73%
|
432,802
|
$1,778,816 | — | 31 Mar 2024 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.73%
|
431,224
|
$1,772,331 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.63%
|
370,246
|
$1,521,711 | — | 31 Mar 2024 | |
| APG Asset Management N.V. |
13F
|
Company |
0.63%
|
371,900
|
$1,415,286 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.56%
|
330,639
|
$1,358,926 | — | 31 Mar 2024 | |
| Newtyn Management, LLC |
13F
|
Company |
0.53%
|
311,000
|
$1,278,210 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.51%
|
302,650
|
$1,243,891 | — | 31 Mar 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.48%
|
281,683
|
$1,157,717 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.47%
|
280,783
|
$1,154,019 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.42%
|
251,238
|
$1,032,588 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.41%
|
244,241
|
$1,003,831 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.4%
|
237,274
|
$975,196 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.4%
|
235,603
|
$968,328 | — | 31 Mar 2024 | |
| Profit Investment Management, LLC |
13F
|
Company |
0.37%
|
220,324
|
$905,531 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.37%
|
216,717
|
$890,707 | — | 31 Mar 2024 | |
| Empowered Funds, LLC |
13F
|
Company |
0.34%
|
201,283
|
$827,273 | — | 31 Mar 2024 | |
| WINTON GROUP Ltd |
13F
|
Company |
0.28%
|
163,826
|
$673,325 | — | 31 Mar 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.27%
|
160,471
|
$659,536 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.26%
|
156,412
|
$642,853 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.24%
|
139,040
|
$571,454 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.23%
|
136,340
|
$560,357 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
125,676
|
$516,528 | — | 31 Mar 2024 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.2%
|
116,902
|
$480,467 | — | 31 Mar 2024 |
Institutional Holders of Vanda Pharmaceuticals Inc. - COMMON STOCK (VNDA) as of Q2 2024
As of 30 Jun 2024,
Vanda Pharmaceuticals Inc. - COMMON STOCK (VNDA) was held by
147 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,532,710 shares.
The largest 10 holders included
BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, Nantahala Capital Management, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
147
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
140
Q2 2024 holders
147
Holder diff
7
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.